SCHEMBL7958283

SCHEMBL7958283

O=C1NC(=S)SC1=Cc1ccc(OCc2ccc(Br)cc2)cc1

nearest known ligand 0.78

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MMP3 P08254 1/20 0.78
MMP13 P45452 1/20 0.78
CISD1 Q9NZ45 1/20 0.71
PTGS2 P35354 3/20 0.70
CTSD P07339 3/20 0.70
PTP4A3 O75365 1/20 0.65
SIRT2 Q8IXJ6 1/20 0.65
SIRT1 Q96EB6 1/20 0.65
SIRT3 Q9NTG7 1/20 0.65
SIRT5 Q9NXA8 1/20 0.65
GSK3B P49841 1/20 0.64
HPGD P15428 6/20 0.63
PTPN1 P18031 2/20 0.63
ADAMTS5 Q9UNA0 1/20 0.63
POLB P06746 1/20 0.62
MAOA P21397 1/20 0.62
MAOB P27338 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7958282 1.00 MMP3 (0.78) MMP3MMP13CISD1PTGS2CTSD
SCHEMBL4054985 0.88 MMP3 (0.78) MMP3MMP13CISD1PTGS2CTSD
SCHEMBL1250159 0.88 PTPN1 (0.82) MMP3MMP13CISD1PTGS2CTSD
SCHEMBL1250155 0.88 PTPN1 (0.82) MMP3MMP13CISD1PTGS2CTSD
SCHEMBL7970200 0.88 MMP3 (0.78) MMP3MMP13CISD1PTGS2CTSD
SCHEMBL4050763 0.88 HPGD (0.82) MMP3MMP13CISD1PTGS2CTSD
SCHEMBL4054980 0.88 MMP3 (0.78) MMP3MMP13CISD1PTGS2CTSD
SCHEMBL4056380 0.88 HPGD (0.82) MMP3MMP13CISD1PTGS2CTSD
SCHEMBL4050762 0.88 HPGD (0.82) MMP3MMP13CISD1PTGS2CTSD
SCHEMBL4051348 0.88 NPC1 (0.79) MMP3MMP13CISD1PTGS2CTSD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6251928-B1 ADMINISTERING BENZYLIDENE RHODANINES WHICH ARE USEFUL AS AGENTS IN TREATING OR PREVENTING CONDITIONS ASSOCIATED WITH BETA-AMYLOID PEPTIDE IN A MAMMAL ELI LILLY AND COMPANY 2001-06-26 US disclosed
EP-0677517-A1 Treatment of Alzheimer's disease employing inhibitors of cathepsin D ELI LILLY AND COMPANY (US) 1995-10-18 EP disclosed